Eyeworld Daily News

2013 APACRS Singapore Daily News Thursday

EyeWorld Today is the official daily of the ASCRS Symposium & Congress. Each issue provides comprehensive coverage editorial coverage of meeting presentations, events, and breaking news

Issue link: http://daily.eyeworld.org/i/145894

Contents of this Issue


Page 13 of 18

ADVERTORIAL The Carl Zeiss Innovation Symposium The cataract free paper session (Friday, July 12, beginning at 16:00 hrs., Hall 3, Level 4) will also focus specifically on cataract issues. Yokrat Ton, MD, Meir Hospital, Kfar Saba, Israel, is just one of the many presenters at the session, and he will present on "Posterior Corneal Astigmatism Contribution to Residual Astigmatism Following Cataract Surgery." Saturday The "Forever Phaco" session (Saturday, July 13, beginning at 11:00 hrs., Hall 1, Level 4), will feature information on a number of cataract topics, mainly looking at updates and practices from those still using the conventional ultrasound based phacoemulsification. Some topics listed include "Cataract Surgery with Dual Pump Technology," "Quick Chop Express for Suprahard Cataracts," and "Cataract Surgery in Eyes with Corneal Ectasia." Looking at IOLs, the issue of change of surface light scattering in different IOLs after cataract surgery will also be examined by Do-Hyung Lee, MD, PhD, Ilsan Paik Hospital, Inje University, Korea, in the "IOL Issues & Advances" symposium (Saturday, July 13, beginning at 11:00 hrs., Hall 2, Level 4). This year's JCRS Symposium (Saturday, July 13, beginning at 14:00 hrs., Hall 2, Level 4) specifically focuses on a number of cataract issues, including use of intracameral antibiotics with cataract surgery. Peter Barry, MD, Dublin, will look at comparing and contrasting stud- ies looking at intracameral antibiotic use for cataract surgery. And Fam Han Bor, MD, Singapore, will look at the "Practical Aspects of Using Intracameral Antibiotics in Cataract Surgery." Two cataract free paper sessions will be offered on Saturday, July 13. Both are scheduled for Hall 3, Level 4, with the first beginning at 14:00 hrs. and the second beginning at 16:00 hrs. Among the topics to be addressed are "Silicone Oil Removal by the Cataract Surgeon," "Excellent Visual Outcomes with Femtosecond Laser Cataract Surgery and Premium Intraocular Lens (IOLs) Implantation- 1 Year Followup," and "Ocular and Systemic Comorbidities in Patients Undergoing Cataract Surgery." Thursday, 11 July at 18:00 hrs–20:00 Nicoll 1, Level 3 Faculty Jod Mehta, MD Kimya Shimizu, MD Sunday Finally, the final day's "Court Martial in Phaco Surgery" symposium (Sunday, July 14, beginning at 8:30 hrs., Room 336, Level 3) will feature a number of cataract topics, including looking at the complicated pediatric cataract, cataract with cornea problems, the cataract with refractive problems, the cataract in a traumatized eye, glaucoma with cataract and the complicated cataract. There will also be a final free paper session focusing specifically on cataract surgery (Sunday, July 14, beginning at 8:30 hrs., Room 330, Level 3). Among the topics to be discussed in the session will be a look at "Decision for Cataract Surgery Based on Higher Order Aberrations in Early Grades of Cataract." EWAP Cornea Day history Dan Reinstein, MD Visante omni Jod Mehta, MD, Singapore, will present "All in One Imaging Solution" about the Crst system to combine OCT and Placido disk technologies, Visante omni. The device, which integrates anterior topography from the ATLAS Corneal Topographer with precision OCT pachymetry, provides anterior and posterior topography with pachymetry analysis. The ATLAS has PathFinder II Corneal Analysis Software, offering a large clinical database that can help refractive surgery patient selection and keratoconus detection. Independent validation has found that PathFinder II has 90% sensitivity and 94% speciCcity in Cnding normal vs. abnormal corneas. The Holladay Report presents results on one page for ease and convenience. SMILE Kimiya Shimizu, MD, Japan, will discuss "SMILE procedure with ReLEx– Exceeds LASIK, 2 Years Clinical Data." SMILE is a new minimally invasive single-step procedure that is a gentle laser technique for refractive error correction. The procedure does not require a Dap, unlike in LASIK. In the procedure, a lenticule is created inside the intact cornea and then Detlev Breyer, MD removed through a small incision. With the procedure, refractive errors are treated with just one femtosecond laser, the VisuMax, which reduces stress, time, and inconvenience for patients through the single treatment step. Dan Reinstein, MD, U.K., will discuss "SMILE and PRESBYOND Laser Blended Vision – ReCnements in Corneal and Refractive Surgery." PRESBYOND Laser Blended Vision works to restore high-quality vision to presbyopia patients. The method offers improved results over traditional monovision. PRESBYOND Laser Blended Vision increases depth of Celd and allows for customized therapy. It uses the CRS-Master treatment planning station and MEL 80 excimer laser, working with myopic, hyperopic, and emmetropic cases. AT LISA tri From left: N. Venkatesh Prajna, MD, Chia Li Pang, Christopher Rapuano, MD, Michael W. Belin, MD, Donald Tan, MD, Elmer Tu, MD, Gail Reggio, and W. Barry Lee, MD, came together Tuesday for a press conference to discuss the first Cornea Day outside the U.S., to be held today prior to the APACRS meeting. Not pictured: Ronald Yeoh, APACRS Annual Meeting organizing chairman. T he Carl Zeiss Innovation Symposium will feature the company's latest offerings in several Celds. It will be held Thursday, July 11, at Nicoll 1, Level 3 from 18:00 hrs.–20:00 hrs. "The aim of this symposium is to provide a platform for an excellent exchange of knowledge and experience," ofCcials said. Detlev Breyer, MD, Germany, will present "The New Generation of Multifocality: Introducing the trifocal AT LISA tri 839MP." The new AT LISA tri 839MP, the third generation ZEISS multifocal IOL in the AT LISA platform, is an innovative trifocal optic presenting excellent intermediate vision. AT LISA tri is the Crst preloaded true MICS IOL and it was launched in Europe in April 2012. 94% patient-reported rate of spectacle independence for intermediate vision, a recent study found. The lens allows "even the most demanding patients" to have clear vision at all distances. EWAP

Articles in this issue

Archives of this issue

view archives of Eyeworld Daily News - 2013 APACRS Singapore Daily News Thursday